PubMed

Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.

Morstyn G, Foote MA, Walker T, Molineux G.

Acta Haematol. 2001;105(3):151-5. Review.PMID: 11463988 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic growth factors in cancer chemotherapy.

Crawford J, Foote M, Morstyn G.

Cancer Chemother Biol Response Modif. 1999;18:250-67. Review.PMID: 10800487 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic growth factors in cancer chemotherapy.

Lieschke GJ, Foote M, Morstyn G.

Cancer Chemother Biol Response Modif. 1997;17:363-89. Review. No abstract available. PMID: 9551221 [PubMed - indexed for MEDLINE]Related articles

Clinical benefits of improving host defences with rHuG-CSF.

Morstyn G, Foote M, Nelson S.

Ciba Found Symp. 1997;204:78-85; discussion 85-7.PMID: 9107412 [PubMed - indexed for MEDLINE]Related articles

Filgrastim (r-metHuG-CSF): the first 10 years.

Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G.

Blood. 1996 Sep 15;88(6):1907-29. Review. No abstract available. PMID: 8822908 [PubMed - indexed for MEDLINE]Related articlesFree article

Hematopoietic growth factors in cancer chemotherapy.

Morstyn G, Foote M, Lieschke GJ.

Cancer Chemother Biol Response Modif. 1996;16:295-314. Review. No abstract available. PMID: 8639388 [PubMed - indexed for MEDLINE]Related articles

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G.

Ann Intern Med. 1994 Oct 1;121(7):492-501.PMID: 7520676 [PubMed - indexed for MEDLINE]Related articlesFree article

Stem cell factor is a potent synergistic factor in hematopoiesis.

Morstyn G, Brown S, Gordon M, Crawford J, Demetri G, Rich W, McGuire B, Foote M, McNiece I.

Oncology. 1994 Mar-Apr;51(2):205-14. Review.PMID: 7515171 [PubMed - indexed for MEDLINE]Related articles

Protection from lethal irradiation by the combination of stem cell factor and tempol.

Liebmann J, DeLuca AM, Epstein A, Steinberg SM, Morstyn G, Mitchell JB.

Radiat Res. 1994 Mar;137(3):400-4.PMID: 7511822 [PubMed - indexed for MEDLINE]Related articles

Endogenous haemopoietic growth factors in neutropenia and infection.

Cebon J, Layton JE, Maher D, Morstyn G.

Br J Haematol. 1994 Feb;86(2):265-74.PMID: 7515265 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic growth factors in cancer chemotherapy.

Morstyn G, Lieschke GJ.

Cancer Chemother Biol Response Modif. 1994;15:367-90. Review. No abstract available. PMID: 7540031 [PubMed - indexed for MEDLINE]Related articles

Clinical applications of filgrastim and stem cell factor in vivo and in vitro.

Morstyn G, Glaspy J, Shpall EJ, LeMaistre F, Briddell R, Menchaca D, Lill M, Jones RB, Tami J, Brown S, et al.

J Hematother. 1994 Winter;3(4):353-5. Review. No abstract available. PMID: 7537611 [PubMed - indexed for MEDLINE]Related articles

The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.

Morstyn G, Foote M, Perkins D, Vincent M.

Stem Cells. 1994;12 Suppl 1:213-27; discussion 227-8. Review.PMID: 7535147 [PubMed - indexed for MEDLINE]Related articlesFree article

Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases.

Daifuku R, Andresen J, Morstyn G.

J Antimicrob Chemother. 1993 Jul;32 Suppl A:91-7. Review.PMID: 7691789 [PubMed - indexed for MEDLINE]Related articles

Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

Grigg A, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM, Sheridan WP.

Bone Marrow Transplant. 1993;11 Suppl 2:23-9.PMID: 8334435 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic growth factors in cancer chemotherapy.

Morstyn G, Sheridan WP.

Cancer Chemother Biol Response Modif. 1993;14:353-70. Review. No abstract available. PMID: 8312108 [PubMed - indexed for MEDLINE]Related articles

Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation.

Lieschke GJ, Ramenghi U, O'Connor MP, Sheridan W, Szer J, Morstyn G.

Br J Haematol. 1992 Nov;82(3):589-95.PMID: 1283080 [PubMed - indexed for MEDLINE]Related articles

Clinical uses of growth factors.

Davis I, Morstyn G.

Baillieres Clin Haematol. 1992 Jul;5(3):753-86. Review.PMID: 1457968 [PubMed - indexed for MEDLINE]Related articles

Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer.

Farag SS, Green MD, Morstyn G, Sheridan WP, Fox RM.

Ann Intern Med. 1992 Mar 15;116(6):473-8.PMID: 1310838 [PubMed - indexed for MEDLINE]Related articles

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM.

Lancet. 1992 Mar 14;339(8794):640-4.PMID: 1371817 [PubMed - indexed for MEDLINE]Related articles

Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF).

Campbell LJ, Maher DW, Tay DL, Boyd AW, Rockman S, McGrath K, Fox RM, Morstyn G.

Br J Haematol. 1992 Mar;80(3):298-304.PMID: 1374626 [PubMed - indexed for MEDLINE]Related articles

The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study.

Cebon J, Lieschke GJ, Bury RW, Morstyn G.

Br J Haematol. 1992 Feb;80(2):144-50.PMID: 1550769 [PubMed - indexed for MEDLINE]Related articles

Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly.

Raghavan D, Bishop JF, Stuart-Harris R, Zalcberg J, Morstyn G, Kefford RF, Matthews JP.

Semin Oncol. 1992 Feb;19(1 Suppl 2):12-6.PMID: 1329217 [PubMed - indexed for MEDLINE]Related articles

Colony-stimulating factors in cancer therapy.

Morstyn G, Sheridan WP.

Cancer Chemother Biol Response Modif. 1992;13:308-26. Review. No abstract available. PMID: 1382528 [PubMed - indexed for MEDLINE]Related articles

Clinical trials of granulocyte colony-stimulating factors for treatment of bone marrow depression associated with cancer chemotherapy.

Lieschke GJ, Morstyn G.

Immunol Ser. 1992;57:671-93. Review. No abstract available. PMID: 1380312 [PubMed - indexed for MEDLINE]Related articles

G-CSF mobilised progenitor cells in autologous transplantation: in vitro and in vivo aspects.

Begley CG, DeLuca E, Rowlings PA, Szer J, Watson D, Juttner C, Morstyn G, Fox RM, Sheridan W.

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:368-71.PMID: 1284309 [PubMed - indexed for MEDLINE]Related articles

Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodies.

Layton JE, Morstyn G, Fabri LJ, Reid GE, Burgess AW, Simpson RJ, Nice EC.

J Biol Chem. 1991 Dec 15;266(35):23815-23.PMID: 1721056 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical profile in Barrett's esophagus: who should be screened for cancer?

Collins BJ, Abbott M, Thomas RJ, Morstyn G, St John DJ.

Hepatogastroenterology. 1991 Aug;38(4):341-4.PMID: 1937380 [PubMed - indexed for MEDLINE]Related articles

The role of granulocyte colony-stimulating factor in cancer chemotherapy.

Davis I, Morstyn G.

Semin Hematol. 1991 Apr;28(2 Suppl 2):25-33. Review. No abstract available. PMID: 1712124 [PubMed - indexed for MEDLINE]Related articles

Characterisation of a cell line (LCC-18) from a cultured human neuroendocrine-differentiated colonic carcinoma.

Lundqvist M, Mark J, Funa K, Heldin NE, Morstyn G, Wedell B, Layton J, Oberg K.

Eur J Cancer. 1991;27(12):1663-8.PMID: 1782079 [PubMed - indexed for MEDLINE]Related articles

Human interleukin-4: an immunomodulator with potential therapeutic applications.

Maher DW, Davis I, Boyd AW, Morstyn G.

Prog Growth Factor Res. 1991;3(1):43-56. Review.PMID: 1777599 [PubMed - indexed for MEDLINE]Related articles

The role of colony stimulating factors in cancer therapy.

Morstyn G, Sheridan WP.

Cancer Chemother Biol Response Modif. 1991;12:307-26. Review. No abstract available. PMID: 1718376 [PubMed - indexed for MEDLINE]Related articles

Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro.

Dempsey PJ, Layton JE, Duhrsen U, Nicola NA, Cebon J, Burgess AW, Morstyn G.

Hybridoma. 1990 Dec;9(6):545-58.PMID: 1706312 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and toxicity of two schedules of high dose epirubicin.

Tjuljandin SA, Doig RG, Sobol MM, Watson DM, Sheridan WP, Morstyn G, Mihaly G, Green MD.

Cancer Res. 1990 Aug 15;50(16):5095-101.PMID: 2379173 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of colony stimulating factors on cancer chemotherapy.

Morstyn G.

Br J Haematol. 1990 Jul;75(3):303-7. Review. No abstract available. PMID: 1696832 [PubMed - indexed for MEDLINE]Related articles

Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity.

Cebon J, Nicola N, Ward M, Gardner I, Dempsey P, Layton J, Dührsen U, Burgess AW, Nice E, Morstyn G.

J Biol Chem. 1990 Mar 15;265(8):4483-91.PMID: 2155231 [PubMed - indexed for MEDLINE]Related articlesFree article

Selective uptake of hematoporphyrin derivative into human cerebral glioma.

Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS.

Neurosurgery. 1990 Feb;26(2):248-54.PMID: 2137904 [PubMed - indexed for MEDLINE]Related articles

The potential role of granulocyte-macrophage colony stimulating factor (GM-CSF) in cancer chemotherapy.

Cebon JS, Morstyn G.

Cancer Surv. 1990;9(1):131-55. Review.PMID: 2276111 [PubMed - indexed for MEDLINE]Related articles

Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies.

Villeval JL, Dührsen U, Morstyn G, Metcalf D.

Br J Haematol. 1990 Jan;74(1):36-44.PMID: 2178672 [PubMed - indexed for MEDLINE]Related articles

The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor.

Cebon JS, Bury RW, Lieschke GJ, Morstyn G.

Eur J Cancer. 1990;26(10):1064-9.PMID: 2148882 [PubMed - indexed for MEDLINE]Related articles

Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.

Morstyn G, Sheridan W, Lieschke G, Cebon J, Layton J, Fox R.

Prog Clin Biol Res. 1990;354B:29-36. Review. No abstract available. PMID: 1700441 [PubMed - indexed for MEDLINE]Related articles

Human granulocyte-macrophage colony-stimulating factor (hGM-CSF): identification of a binding site for a neutralizing antibody.

Nice E, Dempsey P, Layton J, Morstyn G, Cui DF, Simpson R, Fabri L, Burgess A.

Growth Factors. 1990;3(2):159-69.PMID: 1698402 [PubMed - indexed for MEDLINE]Related articles

Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor.

Lieschke GJ, Cebon J, Morstyn G.

Blood. 1989 Dec;74(8):2634-43.PMID: 2684297 [PubMed - indexed for MEDLINE]Related articlesFree article

Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation.

Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM.

Lancet. 1989 Oct 14;2(8668):891-5.PMID: 2477656 [PubMed - indexed for MEDLINE]Related articles

Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.

Morstyn G, Campbell L, Lieschke G, Layton JE, Maher D, O'Connor M, Green M, Sheridan W, Vincent M, Alton K, et al.

J Clin Oncol. 1989 Oct;7(10):1554-62.PMID: 2789274 [PubMed - indexed for MEDLINE]Related articles

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor.

Layton JE, Hockman H, Sheridan WP, Morstyn G.

Blood. 1989 Sep;74(4):1303-7.PMID: 2475185 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacology of the colony-stimulating factors.

Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J.

Trends Pharmacol Sci. 1989 Apr;10(4):154-9. Review.PMID: 2665248 [PubMed - indexed for MEDLINE]Related articles

Diffuse large cell lymphoma: a teaching hospital experience.

Marks DI, Sheridan WP, Ellis DW, Boyd AW, Morstyn G, Green MD, Fox RM.

Aust N Z J Med. 1989 Apr;19(2):159-61. No abstract available. Erratum in: Aust N Z J Med 1989 Aug;19(4):357. PMID: 2475099 [PubMed - indexed for MEDLINE]Related articles

Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.

Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J, Fox RM.

Semin Hematol. 1989 Apr;26(2 Suppl 2):9-13.PMID: 2471275 [PubMed - indexed for MEDLINE]Related articles

Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.

Lieschke GJ, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G, Stuart-Harris R, Kefford RF, Levi J, Sorrell T, et al.

Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S37-42. Review.PMID: 2693108 [PubMed - indexed for MEDLINE]Related articles